メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Clinical significance of major and minor bcr/abl chimeric transcripts in essential thrombocythemia

  • Hironori Yamada
  • , Takaya Murakami
  • , Tsuguhiro Kaneda
  • , Mayumi Tadachi
  • , Makoto Utsumi
  • , Saburo Minami
  • , Motohiro Hamaguchi
  • , Masanobu Kasai
  • , Yoshihisa Kodera
  • , Haruhiko Ohashi
  • , Yoshihisa Morishita
  • , Teruhiko Terasawa
  • , Yumiko Yamasaki
  • , Yoshikazu Kamiya
  • , Mamiko Hattori
  • , Katsuo Yamanaka
  • , Keitaro Tsushita
  • , Masanori Shimoyama

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

抄録

Background: Contradictory results have been reported in terms of detecting bcr/abl transcripts in patients with essential thrombocythemia. The aim of this study was to investigate whether the bcr/abl transcript could be found in patients with essential thrombocythemia (ET). Methods: The bcr/abl transcript was amplified by the RT-nested PCR method using RNA extract from leukocytes taken from 14 essential thrombocythemia patients. The amplified DNAs were electrophoresed in 1% agarose and visualized with ethidium bromide. The DNA bands associated with the bcr/abl transcript were then extracted and followed by DNA sequence analysis. Results: Major bcr/abl transcripts of the b3a2 type and minor ones of the e1a2 type were found in one and two ET patients, respectively. The incidence of bcr/abl transcripts was 21.4% (three of 14 patients). Conclusion: Our experiments confirmed that bcr/abl transcripts are present in some patients with essential thrombocythemia.

本文言語英語
ページ(範囲)472-477
ページ数6
ジャーナルJapanese journal of clinical oncology
巻30
号11
DOI
出版ステータス出版済み - 2000
外部発表はい

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

  1. SDG 3 - すべての人に健康と福祉を
    SDG 3 すべての人に健康と福祉を

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 放射線学、核医学およびイメージング
  • 癌研究

フィンガープリント

「Clinical significance of major and minor bcr/abl chimeric transcripts in essential thrombocythemia」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル